| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $78.1M | — | -19.7% |
| Cost of Revenue | $44.8M | — | -24.8% |
| Gross Profit | $33.3M | — | -11.7% |
| R&D Expense | $1.9M | — | +0.5% |
| SG&A Expense | $17.5M | — | -17.0% |
| Operating Income | -$659K | — | -126.3% |
| Pre-tax Income | $4K | — | -99.9% |
| Income Tax | $46K | — | +15.0% |
| Net Income | -$42K | — | -101.3% |
| EPS (Basic) | $0.00 | — | -100.0% |
| EPS (Diluted) | $0.00 | — | -100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $90.4M | +0.9% | +24.1% |
| Inventory | $61.2M | -15.6% | -32.2% |
| Current Assets | $192.8M | -4.8% | -17.8% |
| Total Assets | $214.9M | -4.7% | -19.0% |
| Current Liabilities | $42.8M | -15.9% | -42.2% |
| Total Liabilities | $45.8M | -17.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $5.5M | — | +288.0% |
| Capital Expenditures | $1.7M | — | +2700.0% |
| Investing Cash Flow | -$1.7M | — | -2700.0% |
| Financing Cash Flow | -$3.0M | — | -883.3% |
| Free Cash Flow | $3.8M | — | +226.2% |
| -46.0% |
| Stockholders' Equity | $169.1M | -0.3% | -6.2% |